Drug Type Personalized antigen vaccine, Therapeutic vaccine |
Synonyms- |
Target- |
Action stimulants |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Non-small cell lung cancer stage IIIA | Phase 2 | China | 16 Jan 2024 | |
Non-small cell lung cancer stage IIIA | Phase 2 | China | 16 Jan 2024 |